A

AZN

AstraZeneca

183.00

-3.68-1.97%
Opening11:14 04/29 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Cash from Operating Activities

14.57B

11.86B

10.35B

9.81B

5.96B

Net Income

12.40B

8.69B

6.90B

2.50B

-265.00M

Depreciation/Depletion & Amortization

5.73B

6.69B

5.39B

5.48B

6.53B

Deferred Taxes

--

--

--

--

--

Non-Cash Items

1.74B

1.44B

1.21B

542.00M

141.00M

Changes in Working Capital

-5.30B

-4.96B

-3.15B

1.28B

-443.00M

Cash from Investing Activities

-6.81B

-7.98B

-4.06B

-2.96B

-11.06B

Capital Expenditures

-5.91B

-4.59B

-3.78B

-2.57B

-2.20B

Other Investing Cash Flow Items, Total

-903.00M

-3.39B

-286.00M

-389.00M

-8.86B

Cash from Financing Activities

-7.54B

-4.00B

-6.57B

-6.82B

3.65B

Financing Cash Flow Items

-70.00M

-817.00M

-886.00M

-1.05B

-178.00M

Total Cash Dividends Paid

-4.97B

-4.63B

-4.48B

-4.36B

-3.86B

Issuance (Retirement) of Stock, Net

-481.00M

-43.00M

33.00M

29.00M

29.00M

Issuance (Retirement) of Debt, Net

-2.02B

1.49B

-1.23B

-1.44B

7.65B

Foreign Exchange Effects

46.00M

-93.00M

-60.00M

-80.00M

-62.00M

Net Change in Cash

269.00M

-208.00M

-346.00M

-55.00M

-1.51B

Cash Interest Paid

1.32B

1.31B

1.08B

849.00M

721.00M

Cash Taxes Paid

2.85B

2.75B

2.37B

1.62B

1.74B